Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IVX | Ann: Investor Presentation | 27/09/24 | 11 | 3.4K | |||
|
|||||||
IVX | Ann: Ph 2 Prostate Cancer Results Strong Safety and 40% Response | 19/09/24 | 18 | 5.5K | |||
|
|||||||
IVX | Ann: Ethics Approval for Phase I/II Non-Meloma Skin Cancer Trial | 12/09/24 | 3 | 1.4K | |||
|
|||||||
IVX | Ann: Section 708A Cleansing Statement | 11/09/24 | 0 | 180 | |||
|
|||||||
IVX | Ann: Application for quotation of securities - IVX | 11/09/24 | 0 | 149 | |||
|
|||||||
IVX | Ann: Change of Director's Interest Notice - Alan Yamashita | 09/09/24 | 0 | 260 | |||
|
|||||||
IVX | Ann: Change of Director's Interest Notice- Thian Chew | 09/09/24 | 0 | 187 | |||
|
|||||||
IVX | Ann: Section 708A Cleansing Statement | 09/09/24 | 0 | 136 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |